ARIELLE ADES: Open Payments
NPI 1417625930 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,090 in 86 payments from 17 companies in 2025. Trend: 2023 $787 · 2024 $1,896 · 2025 $9,090
Consulting: $3,789Speaker / faculty: $2,641Food & beverage: $2,633Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $2,953 |
| Regeneron Pharmaceuticals, Inc. | 4 | $1,359 |
| Arcutis Biotherapeutics, Inc. | 10 | $1,332 |
| E.R. Squibb & Sons, L.L.C. | 1 | $984 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $709 |
| Janssen Biotech, Inc. | 10 | $492 |
| GENZYME CORPORATION | 7 | $489 |
| PFIZER INC. | 11 | $141 |
| ABBVIE INC. | 6 | $130 |
| LEO Pharma Inc. | 2 | $125 |
Products named: DUPIXENT, Zoryve, Cabtreo, TREMFYA, OTEZLA, CIBINQO, ADBRY, SKYRIZI.
Industry payments across CO — which companies pay providers there.
